Weimei Shi

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Signaling Pathway

Long Noncoding Rna

Top Venues

Future medicinal chemistry

Food & function

Drug design, development and therapy

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Fang Peng, Xianhua Huang, Weimei Shi, Yaosheng Xiao, Qi Jin, Linfu Li, Daohua Xu, Longhuo Wu
5,7,3',4'-tetramethoxyflavone ameliorates cholesterol dysregulation by mediating SIRT1/FOXO3a/ABCA1 signaling in osteoarthritis chondrocytes. Future medicinal chemistry 13 (24) (2021)
Yizhou Zheng, Rui Zhang, Weimei Shi, Linfu Li, Hai Liu, Zhixi Chen, Longhuo Wu
Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food & function 11 (10) (2021)
Hao Huang, Yizhou Zheng, Linfu Li, Weimei Shi, Rui Zhang, Hai Liu, Zhixi Chen, Longhuo Wu
The roles of post-translational modifications and coactivators of STAT6 signaling in tumor growth and progression. Future medicinal chemistry 12 (21) (2020)
Linfu Li, Renbing Shi, Weimei Shi, Rui Zhang, Longhuo Wu
Oxysophocarpine protects airway epithelial cells against inflammation and apoptosis by inhibiting miR-155 expression. Future medicinal chemistry 12 (16) (2020)
Xianhua Huang, Zhixi Chen, Weimei Shi, Rui Zhang, Linfu Li, Hai Liu, Longhuo Wu
TMF inhibits miR-29a/Wnt/β-catenin signaling through upregulating Foxo3a activity in osteoarthritis chondrocytes. Drug design, development and therapy 13 (2019)
Jianhong Zhang, Zhixi Chen, Xianhua Huang, Weimei Shi, Rui Zhang, Meiling Chen, Hao Huang, Longhuo Wu
Insights on the Multifunctional Activities of Magnolol. BioMed research international 2019 (2019)